Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Apr 1;4(2):132-142.
doi: 10.1016/S2055-6640(20)30258-2.

Highlights from the 8th International Workshop on HIV Persistence during Therapy, 12-15 December 2017, Miami, FL, USA

Christina K Psomas  1 , Alain Lafeuillade  2 , David Margolis  3 , Karl Salzwedel  4 , Mario Stevenson  5 , Nicolas Chomont  6 , Guido Poli  7 , Jean-Pierre Routy  8
Affiliations
Editorial

Highlights from the 8th International Workshop on HIV Persistence during Therapy, 12-15 December 2017, Miami, FL, USA

Christina K Psomas et al. J Virus Erad. .

Abstract

Over 4 days, more than 500 scientists involved in HIV persistence research shared their new unpublished data and designed future perspectives towards ART-free HIV remission. This 8th International Workshop on HIV Persistence followed the format of past conferences but further focused on encouraging participation of young investigators, especially through submission of oral and poster presentations. The topic of the workshop was HIV persistence. Consequently, issues of HIV reservoirs and HIV cure were also addressed. In this article, we report the discussions as closely as possible; however, all the workshop abstracts can be found online at www.viruseradication.com.

Keywords: HIV persistence, HIV reservoirs, HIV cure, HIV functional cure, HIV eradication.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Use of ‘transcription profiling’ to investigate the mechanisms that regulate HIV transcription in vivo (after Yukl et al., Sci Transl Med 2017, in press)
Figure 2.
Figure 2.
Steps to eliminate HIV infection (after DM Margolis)
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Chun TW, Moir S, Fauci AS. HIV reservoirs as obstacles and opportunities for an HIV cure. Nat Immunol 2015; 16: 584– 589. - PubMed
    1. Sneller MC, Justement JS, Gittens KR et al. . A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection. Sci Transl Med 2017; 9: pii: eaan8848. - PMC - PubMed
    1. Scheid JF, Horwitz JA, Bar-On Y et al. . HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption. Nature 2016; 535: 556– 560. - PMC - PubMed
    1. Bar KJ, Sneller MC, Harrison LJ et al. . Effect of HIV antibody VRC01 on viral rebound after treatment interruption. N Engl J Med 2016; 375: 2037– 2050. - PMC - PubMed
    1. Nishimura Y, Gautam R, Chun TW et al. . Early antibody therapy can induce long-lasting immunity to SHIV. Nature 2017; 543: 559– 563. - PMC - PubMed

Publication types

LinkOut - more resources